First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab
{{output}}
A 68-year-old male, who was undergoing XELOX plus trastuzumab therapy for gastric cancer, developed proteinuria, hematuria, and progressive increase in creatinine after 3 months. Subsequently, the patient also experienced hemoptysis, nasal bleeding. Chest CT e... ...
